Comparison of cyclosporine concentrations in renal transplant recipients using ACMIA and mFPIA methods

Clinical Biochemistry

Volumn 37, Issue 11, 2004, Pages 1016-1021

  Kagawa, Yoshiyuki ^a   Yanagawa, Makoto ^b   Muraki, Yuichi ^a   Iwamoto, Takuya ^a   Mizutani, Hideki ^a   Sugimura, Yoshiki ^a   Kojima, Michio ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI MATSUSAKA GENERAL HOSPITAL   (Japan)

Author keywords

ACMIA; Blood concentration; Cyclosporine; Metabolite; mFPIA; Renal transplant

Indexed keywords

CYCLOSPORIN A;

ACCURACY; AFFINITY COLUMN MEDIATED IMMUNOASSAY; ARTICLE; CALIBRATION; CONTROLLED STUDY; CROSS REACTION; DEVICE; DRUG DETERMINATION; DRUG MONITORING; FLUORESCENCE POLARIZATION IMMUNOASSAY; GRAFT FAILURE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SAMPLING;

ANTIBODIES, MONOCLONAL; CYCLOSPORINE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; IMMUNOASSAY; KIDNEY TRANSPLANTATION;

EID: 6344237614     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.07.004     Document Type: Article

References (23)

1. B.D. Kahan Cyclosporine N. Engl. J. Med. 321 1989 1725 1738
2. P.A. Keown New concepts in cyclosporine monitoring Curr. Opin. Nephrol. Hypertens. 11 2002 619 626
3. A. Fahr Cyclosporin clinical pharmacokinetics Clin. Pharmacokinet. 24 1993 472 495
4. A. Trull, K. Hue, and K. Tan Cross-correlation of cyclosporine concentrations and biological measures of kidney and liver function in heart and heartâ€"lung transplant recipients Clin. Chem. 36 1990 1474 1478
5. Y. Kagawa, J. Sawada, and S. Yamada Relationship between development of nephrotoxicity and blood concentration of cyclosporine A in bone-marrow transplanted recipients who received the continuous intravenous infusion Biol. Pharm. Bull. 26 2003 1115 1119
6. 2 monitoring: an international consensus statement Transplantation 73 2002 S12 S18
7. M. Oellerich, and V.W. Armstrong Two-hour cyclosporine concentration determination: an appropriate tool to monitor Neoral therapy? Ther. Drug Monit. 24 2002 40 46
8. M. Oellerich, V.W. Armstrong, and B. Kahan Lake Louise consensus conference on cyclosporine monitoring in organ transplantation: report of the consensus panel Ther. Drug Monit. 17 1995 642 654
9. R.G. Morris, K.F. Ilett, and S.E. Tett Cyclosporine monitoring in Australia: 2002 update of consensus guidelines Ther. Drug Monit. 24 2002 677 688
10. B.D. Kahan, P. Keown, G.A. Levy, and A. Johnston Therapeutic drug monitoring of immunosuppressant drugs in clinical practice Clin. Ther. 24 2002 330 350
11. W. Steimer Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin. Chem. 45 1999 371 381
12. S. Eksborg Evaluation of method-comparison data Clin. Chem. 27 1981 1311 1312
13. A. Asberg Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients Drugs 63 2003 367 378
14. C.Y. Wu, L.Z. Benet, and M.F. Hebert Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine Clin. Pharmacol. Ther. 58 1995 492 497
15. R.W. Yatscoff, T.G. Rosano, and L.D. Bowers The clinical significance of cyclosporine metabolites Clin. Biochem. 24 1991 23 35
16. A. Lindholm Factors influencing the pharmacokinetics of cyclosporine in man Ther. Drug Monit. 13 1991 465 477
17. G.E. Schumacher Therapeutic Drug Monitoring 1995 Appleton and Lange East Norwalk 449 468
18. A.R. Terrell, T.M. Daly, and K.G. Hock Evaluation of a non-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzer Clin. Chem. 48 2002 1059 1065
19. L. Vernillet, J.M. Kovariik, and R. Freiburghaus Blood cyclosporine A and metabolite kinetic profiles after administration of Sandimmune soft gelatine capsules and Neoral in transplant recipients Transplant. Proc. 26 1994 2964 2968
20. E. Schutz, F. Streit, and V.C. Dias CsA immunoassays in comparison to LC-MS/MS, is there a difference between trough (C0) and C2 levels? Ther. Drug Monit. 23 2001 471
21. A. Johnston, G. Chusney, E. Schutz, M. Oellerich, T.D. Lee, and D.W. Holt Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose (C2) Ther. Drug Monit. 25 2003 167 173
22. M.J. Garrido, J. Hermida, and J.C. Tutor Relationship between cyclosporine concentrations obtained using the Roche Cobas Integra and Abbott TDx monoclonal immunoassays in pre-dose and two hour post-dose blood samples from kidney transplant recipients Ther. Drug Monit. 24 2002 785 788
23. S.J. Soldin, B.W. Steele, D.L. Witte, E. Wang, and R.J. Elin College of American Pathologists study. Lack of specificity of cyclosporine immunoassays. Results of a College of American Pathologists study Arch. Pathol. Lab. Med. 127 2003 19 22